Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$45.01 - $65.47 $585,130 - $851,110
-13,000 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$35.79 - $48.81 $35,790 - $48,810
-1,000 Reduced 7.14%
13,000 $632,000
Q2 2020

Aug 14, 2020

SELL
$24.95 - $48.38 $13,348 - $25,883
-535 Reduced 3.68%
14,000 $677,000
Q1 2020

May 15, 2020

BUY
$16.96 - $34.16 $246,513 - $496,515
14,535 New
14,535 $404,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $624M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.